During the past decade, AUSL - IRCCS Santa Maria Nuova; U.O. Day Hospital di Oncologia conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "AUSL - IRCCS Santa Maria Nuova; U.O. Day Hospital di Oncologia" #1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator and "Institut Jules Bordet/Clinical Trials Support Unit (IJB/CTSU)" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "AUSL - IRCCS Santa Maria Nuova; U.O. Day Hospital di Oncologia" are "Breast Cancer" (1 trials), "Diffuse Large B-Cell Lymphoma" (1 trials), "Gastric Cancer" (1 trials), "Non-Hodgkin's Lymphoma" (1 trials) and "Solid Tumor" (1 trials). Many other conditions were trialed in "AUSL - IRCCS Santa Maria Nuova; U.O. Day Hospital di Oncologia" in a lesser frequency.

Most popular intervention types in "AUSL - IRCCS Santa Maria Nuova; U.O. Day Hospital di Oncologia" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (3 trials), "Doxorubicin" (3 trials), "Trastuzumab" (3 trials), "Paclitaxel" (2 trials) and "Pertuzumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "AUSL - IRCCS Santa Maria Nuova; U.O. Day Hospital di Oncologia" are 6 trials for "All" genders.

Currently, there are NaN active trials in "AUSL - IRCCS Santa Maria Nuova; U.O. Day Hospital di Oncologia". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in AUSL - IRCCS Santa Maria Nuova; U.O. Day Hospital di Oncologia, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in AUSL - IRCCS Santa Maria Nuova; U.O. Day Hospital di Oncologia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".